Related Experiment Video
Updated: Mar 29, 2026
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
5.5K
Cardiomyopathy from 1,1-Difluoroethane Inhalation.
Suwen Kumar1, Tejaswini Joginpally2, David Kim2
1Department of Medicine, Michigan State University, East Lansing, MI, 48824, USA. suwen.kumar@hc.msu.edu.
Cardiovascular Toxicology
|November 29, 2015
Summary
Inhaling 1,1-difluoroethane (DFE) aerosol products can cause severe health issues, including heart damage. This case study highlights acute myocardial injury from DFE abuse, emphasizing its potential toxicity.
Area of Science:
- Toxicology
- Cardiology
- Environmental Health
Background:
- Consumer aerosol products are often abused for psychoactive effects.
- This abuse can lead to serious adverse health events, including sudden sniffing death.
- Cardiomyopathy is a rare but serious consequence associated with 1,1-difluoroethane (DFE) use.
Observation:
- A 33-year-old male presented with acute myocardial injury and global hypokinesis.
- The patient also experienced rhabdomyolysis, acute kidney injury, and fulminant hepatitis.
- These symptoms occurred after approximately two days of continuous DFE 'huffing'.
Findings:
- Diagnostic workup excluded underlying coronary artery disease and other potential causes.
- Cardiac function demonstrated improvement over time following cessation of DFE exposure.
- The patient's presentation was directly attributed to DFE toxicity.
Implications:
- This case underscores the potential for DFE to induce severe cardiac and systemic toxicity.
- Mechanisms may involve catecholamine surge, coronary vasospasm, or direct cellular damage.
- Awareness among healthcare providers is crucial for diagnosing and managing DFE-related emergencies.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
751
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
751
01:25Cardiomyopathy I: Introduction and Classification
800
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
800
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
809
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
809
01:21Acute Respiratory Failure-II
1.5K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.5K
01:26Pneumothorax-I
2.0K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
2.0K
01:30Acute Respiratory Failure-III
1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K